Published in Lab Business Week, October 23rd, 2005
The investment consists of $3.19 million that closed last week and an additional funding commitment of $2.50 million upon reaching certain milestones within the next 12 months. The financing was led by Sanderling Ventures and included participation from Life Science Angels.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.